CYCC icon

Cyclacel Pharmaceuticals

17 hedge funds and large institutions have $12.8M invested in Cyclacel Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

Holders
17
Holders Change
+8
Holders Change %
+88.89%
% of All Funds
0.3%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
1
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
PVI
1
Pura Vida Investments
New York
$3.71M 475,000 +475,000 New
IC
2
Ikarian Capital
Texas
$3.06M 391,450 +391,450 New
CC
3
Commodore Capital
New York
$2.07M 264,690 +264,690 New
ACP
4
Acuta Capital Partners
California
$1.17M 150,000 +150,000 New
AAA
5
Affinity Asset Advisors
New York
$918K 117,545 +117,545 New
Morgan Stanley
6
Morgan Stanley
New York
$898K 115,000 +115,000 New
RJFSA
7
Raymond James Financial Services Advisors
Florida
$445K 57,006 +11,250 +25%
BFM
8
Boothbay Fund Management
New York
$321K 41,158 +41,158 New
Vanguard Group
9
Vanguard Group
Pennsylvania
$121K 15,458 +15,458 New
VF
10
Virtu Financial
New York
$80K 10,293 +10,293 New
FDCDDQ
11
Federation des caisses Desjardins du Quebec
Quebec, Canada
$15.6K 2,000 -1,000 -33%
ASN
12
Advisory Services Network
Georgia
$11K 1,394 +1,394 New
Wells Fargo
13
Wells Fargo
California
$4K 527
RE
14
RBC Europe
United Kingdom
$2.17K 278
TRCT
15
Tower Research Capital (TRC)
New York
$1K 81 +81 New
SM
16
Sabby Management
Florida
-125,578 Closed
WS
17
Wedbush Securities
California
-29,012 Closed
UBS Group
18
UBS Group
Switzerland
$0 2 -2,992 -100%
Bank of America
19
Bank of America
North Carolina
-56 Closed
BlackRock
20
BlackRock
New York
$0 39
CFGS
21
Concourse Financial Group Securities
Alabama